Latest News

Epilepsy community seeks redefinition of bioequivalence from FDA

For several years, epilepsy practitioners have questioned the U.S. Food and Drug Administration?s (FDA) definition of bioequivalence as it applies to narrow therapeutic index (NTI) drugs, such as those used for epilepsy. In response to these concerns, the FDA has sponsored 3 studies of antiepileptic drugs and also convened an advisory board to help determine which drugs are NTI.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • Depression as a risk factor for dementia: Link is independent of dementia-related brain changes

  • Popping pills to pushing needles: Prescription opioid abuse among young adults in NYC

  • Preterm children do not have an increased risk for dyscalculia, new research suggests

  • Management of anticoagulant-associated intracerebral hemorrhage

  • Benefits of e-cigarettes outweigh harms, current evidence suggests

  • New mapping approach lets scientists zoom in and out as the brain processes sound

  • Insular cortex alterations in mouse models of autism

  • Political attitudes derive from body and mind: 'Negativity bias' explains difference between liberals and conservatives

  • Study of twins discovers gene mutation linked to short sleep duration

  • First grade reading suffers in segregated schools

  •